Metabolomics Market to Reach $6.66 Bn, Globally, by 2030 at 12.2% CAGR

Newstrail

Metabolomics Market Growth

According to the report published by Allied Market Research, the global metabolomics market was estimated at $2.03 billion in 2020 and is expected to hit $6.66 billion by 2030, registering a CAGR of 12.2% from 2021 to 2030.

Drivers, restraints, and opportunities-

The fact that metabolomics has the ability to detect a large number of metabolites from fluid or tissue sample in a single step and it can also yield great amounts leads to a steep rise in demand for metabolomics, thereby driving the growth of the market. On the other hand, high cost of metabolomics instruments and scarcity of professionals restrain the growth to some extent. However, technological advancements in analytical techniques and upsurge in R&D expenditure are expected to create an array of opportunities in the industry.

Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/525

Metabolomics includes the application of a variety of analytical methods such as spectroscopy, chromatography, and multivariate analysis for identification of quantification of various metabolites. The analytical methods facilitate classification of a multitude of known and unknown metabolites in the reaction. The comprehensive nature of metabolites can be applied in many fields and assist in the development of new treatment and diagnostics in human diseases.

The metabolomics bioinformatics tools and services segment to maintain the lion’s share-

On the basis of product & services, the metabolomics bioinformatics tools and services segment accounted for the highest market share in 2020, generating nearly three-fourths of the global metabolomics market. The same segment is also anticipated to cite the fastest CAGR of 12.7% from 2021 to 2030. This is owing to surge in amount of data generated in metabolomics processes which needs proper management through the use of bioinformatics tools.

Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/525

The biomarker discovery segment to lead the trail-

On the basis of application, the biomarker discovery segment generated the highest share in 2020, holding more than two-fifths of the global metabolomics market, due to surge in prevalence of cancer. The personalized medicine segment, however, is expected to cite the fastest CAGR of 15.6% from 2021 to 2030. Increase in awareness related to the use of personalized medicine and extensive use of metabolomics in it drive the growth of the segment.

North America to dominate by 2030-

On the basis of region, North America contributed to the major market share in terms of revenue 2020, holding more than two-fifths of the global metabolomics market, owing to surge in research activities which involve the use of metabolomics. Asia-Pacific, on the other hand, is projected to cite the fastest CAGR of 13.9% from 2021 to 2030. This is due to rise in awareness related to use of metabolomics.

Prominent market players-

  • Bio-Rad Laboratories INC.
  • Agilent Technologies INC.
  • Bruker corporation
  • Danaher Corporation
  • Human Metabolome Technologies INC.
  • LECO Corporation
  • Metabolon INC.
  • BiocratesLife Science AG
  • Water Corporation
  • Shimadzu Corporation

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the Metabolomics market, and the current trends &future estimations to elucidate imminent investment pockets.
  • It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing metabolomics market opportunities.
  • Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:

Allied Market Research projects the behavioral rehabilitation market to reach $777.2 billion worldwide by 2033

Microsurgery Market is growing at a CAGR of 6% from 2024 to 2033

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Allied Market Research

Allied Market Research

Allied Market Research (AMR) is approved by the Newstrail editorial board to share timely, data-driven insights. As a trusted leader in market research and analysis across multiple industries, AMR delivers in-depth reports and expert commentary to help businesses stay ahead of emerging trends.